ClinicalTrials.Veeva
Menu

Find clinical trials for Acute Myeloid Leukemia (AML) in Taipei City

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Acute Myeloid Leukemia
Leukemia
Myeloid Leukemia
Myelodysplastic Syndromes
Preleukemia
Chronic Myelomonocytic Leukemia
Syndrome

Acute Myeloid Leukemia (AML) trials near Taipei City, TWN:

A Study of Oral Venetoclax Tablets and Oral Azacitidine as Maintenance Therapy in Adult Participants With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy (VIALE-M)

This study will be conducted in two parts. Part 1 will be the Dose Confirmation portion to determine recommended Phase 3 dose (RPTD) of venetoclax in...

Active, not recruiting
Acute Myeloid Leukemia (AML)
Drug: Venetoclax
Drug: Azacitidine

Phase 3

AbbVie
AbbVie

Taipei City, Taipei, Taiwan and 160 other locations

This is an open-label, multi-center Phase 1 study of LY3410738, an oral, covalent isocitrate dehydrogenase (IDH) inhibitor, in patients with IDH1 and...

Active, not recruiting
Acute Myeloid Leukemia (AML)
Chronic Myelomonocytic Leukemia (CMML)
Drug: Azacitidine
Drug: LY3410738

Phase 1

Lilly
Lilly

Taipei, Taiwan and 36 other locations

VEN+AZA alone for the treatment of participants with newly diagnosed Acute Myeloid Leukemia (AML) with a mutation...

Enrolling
Leukemia, Myeloid, Acute
Drug: Venetoclax (VEN)
Drug: Azacitidine (AZA)

Phase 3

Janssen (J&J Innovative Medicine)
Janssen (J&J Innovative Medicine)

Taipei, Taiwan and 180 other locations

The purpose of this extension study is to provide venetoclax and obtain long-term safety data for subjects who continue to tolerate and derive benefi...

Active, not recruiting
Acute Lymphoblastic Leukemia
Chronic Lymphocytic Leukemia
Drug: Venetoclax

Phase 3

AbbVie
AbbVie

Taipei City, Taipei, Taiwan and 55 other locations

Acute Myeloid Leukaemia (AML) is an aggressive and rare cancer of myeloid cells (a white blood cell responsible f...

Active, not recruiting
Acute Myeloid Leukemia (AML)
Drug: Placebo
Drug: Azacitidine

Phase 3

AbbVie
AbbVie

Taipei City, Taiwan and 171 other locations

This is a multi-center, randomized, double-blinded, placebo controlled trial.

Enrolling
Adult Acute Myeloid Leukemia
Drug: mocravimod

Phase 3

Priothera

Taipei, Taiwan and 104 other locations

combination with chemotherapy in participants with newly diagnosed FMS-like tyrosine kinase 3 (FLT3)-internal tandem duplication (ITD) negative acute...

Enrolling
Leukemia
Drug: Quizartinib
Drug: Placebo

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Taipei, Taiwan and 277 other locations

the dose-limiting toxicity (DLT) of study treatment in patients with Acute Myeloid Leukemia (AML) and Mantle Cell...

Enrolling
Acute Myeloid Leukemia
Lymphoma, Mantle-Cell
Drug: PEP07

Phase 1

PharmaEngine

Taipei, Taiwan and 4 other locations

available therapy (BAT) on overall survival (OS) in subjects with acute myeloid leukemia (AML) who are in second ...

Active, not recruiting
Acute Myeloid Leukemia
Other: Observation
Other: Montanide

Phase 3

Sellas Life Sciences

Taipei, Taiwan and 72 other locations

A phase 1/2 dose escalation / dose expansion study of Enzomenib (DSP-5336) in adult patients with acute leukemia....

Enrolling
Leukemia, Lymphocytic, Acute
Leukemia, Myeloid, Acute
Drug: azoles
Drug: Azacitidine (AZA)

Phase 1, Phase 2

Sumitomo Pharma
Sumitomo Pharma

Taipei, Taiwan and 91 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems